Catalyst Pharmaceuticals Stock Forecast - Naive Prediction

CPRX Stock  USD 21.19  0.29  1.35%   
The Naive Prediction forecasted value of Catalyst Pharmaceuticals on the next trading day is expected to be 20.28 with a mean absolute deviation of 0.41 and the sum of the absolute errors of 25.64. Catalyst Stock Forecast is based on your current time horizon.
  
At this time, Catalyst Pharmaceuticals' Receivables Turnover is fairly stable compared to the past year. Fixed Asset Turnover is likely to rise to 141.06 in 2024, whereas Inventory Turnover is likely to drop 5.13 in 2024. . Net Income Applicable To Common Shares is likely to rise to about 100.3 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 57 M in 2024.
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Catalyst Pharmaceuticals' financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2004-12-31
Previous Quarter
375.7 M
Current Value
442.3 M
Quarterly Volatility
92.9 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Catalyst Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Catalyst Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Catalyst Pharmaceuticals Naive Prediction Price Forecast For the 27th of November

Given 90 days horizon, the Naive Prediction forecasted value of Catalyst Pharmaceuticals on the next trading day is expected to be 20.28 with a mean absolute deviation of 0.41, mean absolute percentage error of 0.29, and the sum of the absolute errors of 25.64.
Please note that although there have been many attempts to predict Catalyst Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Catalyst Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Catalyst Pharmaceuticals Stock Forecast Pattern

Backtest Catalyst PharmaceuticalsCatalyst Pharmaceuticals Price PredictionBuy or Sell Advice 

Catalyst Pharmaceuticals Forecasted Value

In the context of forecasting Catalyst Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Catalyst Pharmaceuticals' downside and upside margins for the forecasting period are 18.38 and 22.18, respectively. We have considered Catalyst Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
21.19
20.28
Expected Value
22.18
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Catalyst Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Catalyst Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.7105
BiasArithmetic mean of the errors None
MADMean absolute deviation0.4136
MAPEMean absolute percentage error0.0195
SAESum of the absolute errors25.6405
This model is not at all useful as a medium-long range forecasting tool of Catalyst Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Catalyst Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Catalyst Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Catalyst Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
19.3621.2323.10
Details
Intrinsic
Valuation
LowRealHigh
20.4022.2724.14
Details
Bollinger
Band Projection (param)
LowMiddleHigh
19.7621.8924.02
Details
7 Analysts
Consensus
LowTargetHigh
21.0223.1025.64
Details

Other Forecasting Options for Catalyst Pharmaceuticals

For every potential investor in Catalyst, whether a beginner or expert, Catalyst Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Catalyst Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Catalyst. Basic forecasting techniques help filter out the noise by identifying Catalyst Pharmaceuticals' price trends.

Catalyst Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Catalyst Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Catalyst Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Catalyst Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Catalyst Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Catalyst Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Catalyst Pharmaceuticals' current price.

Catalyst Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Catalyst Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Catalyst Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Catalyst Pharmaceuticals stock market strength indicators, traders can identify Catalyst Pharmaceuticals entry and exit signals to maximize returns.

Catalyst Pharmaceuticals Risk Indicators

The analysis of Catalyst Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Catalyst Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting catalyst stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Catalyst Stock Analysis

When running Catalyst Pharmaceuticals' price analysis, check to measure Catalyst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalyst Pharmaceuticals is operating at the current time. Most of Catalyst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Catalyst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalyst Pharmaceuticals' price. Additionally, you may evaluate how the addition of Catalyst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.